Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252434 · ClinicalTrials.gov registry record · Phase 1
Behavioral Therapy Development for Methamphetamine Abuse
A Phase 1 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 1
- Development phase
NCT00252434 is a Phase 1 study that was terminated before completion, run by University of California, Los Angeles.
The verdict
NCT00252434, a Phase 1 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to evaluate whether a specially developed group counseling approach is better able to help HIV-positive gay and bisexual men (GBM) who use crystal meth to stop using methamphetamines, reduce sexual risk behaviors, and stay on their HIV medications than a standard drug treatment program. Another purpose is to determine whether having a drug abuse treatment program in an HIV medical clinic makes it easier to attend treatment than going to a separate location for drug abuse treatment.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy Development for Methamphetamine Abuse
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-08 |
| Est. Completion | 2007-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00252434
The ClinicalTrials.gov registry entry for NCT00252434 describes a study currently listed as terminated, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy Development for Methamphetamine Abuse is the first listed.
NCT00252434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00252434 about?
NCT00252434 is a clinical study titled "Behavioral Therapy Development for Methamphetamine Abuse". The purpose of this study is to evaluate whether a specially developed group counseling approach is better able to help HIV-positive gay and bisexual men (GBM) who use crystal meth to stop using methamphetamines, reduce sexual risk behaviors, and stay on their HIV medications than a standard drug tr...
What is the current status of trial NCT00252434?
This trial is currently terminated. It is a Phase 1 study. The study started on 2004-08. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00252434?
The interventions under investigation include: Cognitive Behavioral Therapy Development for Methamphetamine Abuse (BEHAVIORAL).
Who is sponsoring clinical trial NCT00252434?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.